Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2613944636ab2fdf3f83ef2d4b304f0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
filingDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d799cf099f8a03b55073dd9d78ba82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d1417ce6c31c0350d7f078db57e123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51120271dfc1c92aec0ea940d95b7222 |
publicationDate |
2005-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1511493-A1 |
titleOfInvention |
Use of peroxovanadium compounds as tumour cell growth suppressor |
abstract |
The present invention relates to the use of peroxovanadium compounds as antitumorigenic agents. These compounds have been found to be suitable, at low dosages, as antitumorigenic agents in the treatment of cancer, such as breast cancer and prostate cancer. It has been found that even at low dosages, these compounds can prevent or arrest further tumour growth. |
priorityDate |
2002-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |